Reliability of risk-based screening for hepatitis C virus infection among pregnant women in Egypt

Journal of Infection

Volumn 70, Issue 5, 2015, Pages 512-519

  El Kamary, Samer S ^a   Hashem, Mohamed ^a   Saleh, Doa'a A ^b   Ehab, Mohamed ^b   Sharaf, Sahar A ^b   El Mougy, Fatma ^b   Abdelsalam, Lobna ^b   Jhaveri, Ravi ^c   Aboulnasr, Ahmed ^b   El Ghazaly, Hesham ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b CAIRO UNIVERSITY   (Egypt)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Egypt; Hepatitis C; Mass screening; Pregnancy; Risk factors

Indexed keywords

HEPATITIS ANTIBODY; VIRUS RNA; HEPATITIS C ANTIBODY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; EGYPT; FEMALE; HEALTH CARE PERSONNEL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MASS SCREENING; PREGNANCY; PRENATAL DIAGNOSIS; RELIABILITY; RISK ASSESSMENT; RISK FACTOR; BLOOD; GENETICS; HEPACIVIRUS; HEPATITIS C, CHRONIC; ISOLATION AND PURIFICATION; MIDDLE AGED; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; REPRODUCIBILITY; YOUNG ADULT;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; EGYPT; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; MASS SCREENING; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; REPRODUCIBILITY OF RESULTS; RISK FACTORS; YOUNG ADULT;

EID: 84927112119     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2015.01.009     Document Type: Article

References (40)

1. Mohd Hanafiah K., Groeger J., Flaxman A.D., Wiersma S.T. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013, 57(4):1333-1342.
2. Armstrong G.L., Wasley A., Simard E.P., McQuillan G.M., Kuhnert W.L., Alter M.J. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006, 144(10):705-714.
3. El-Kamary S.S., Serwint J.R., Joffe A., Santosham M., Duggan A.K. Prevalence of hepatitis C virus infection in urban children. JPediatr 2003, 143(1):54-59.
4. El-Kamary S.S., Jhaveri R., Shardell M.D. All-cause, liver-related, and non-liver-related mortality among HCV-infected individuals in the general US population. Clin Infect Dis 2011, 53(2):150-157.
5. El-Zanaty F.H., Way A.A. Egypt. Wizarat al-Sihhah wa-al-Sukkan. Egypt demographic and health survey, 2008 2009, Ministry of Health and Population, Cairo, Egypt, 431 pp. p.
6. Institute of Medicine Hepatitis and liver cancer: a national strategy for prevention and control of hepatitis B and C 2010, The National Academies Press, Washington, DC.
7. Kenny-Walsh E. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. N Engl J Med 1999, 340(16):1228-1233.
8. Seeff L.B. Natural history of chronic hepatitis C. Hepatology 2002, 36(5 suppl. 1):S35-S46.
9. Shakil A.O., Conry-Cantilena C., Alter H.J., Hayashi P., Kleiner D.E., Tedeschi V., et al. Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. The Hepatitis C Study Group. Ann Intern Med 1995, 123(5):330-337.
10. Verna E.C., Brown R.S. Hepatitis C virus and liver transplantation. Clin Liver Dis 2006, 10(4):919-940.
11. Lehman E.M., Wilson M.L. Epidemic hepatitis C virus infection in Egypt: estimates of past incidence and future morbidity and mortality. J Viral Hepat 2009, 16(9):650-658.
12. Davis K.L., Mitra D., Medjedovic J., Beam C., Rustgi V. Direct economic burden of chronic hepatitis C virus in a United States managed care population. J Clin Gastroenterol 2011, 45(2):e17-24.
13. Su J., Brook R.A., Kleinman N.L., Corey-Lisle P. The impact of hepatitis C virus infection on work absence, productivity, and healthcare benefit costs. Hepatology 2010, 52(2):436-442.
14. United States Department of Health and Human Services Combating the silent epidemic of viral hepatitis: action plan for the prevention, care & treatment of viral hepatitis 2011, 76. U.S. Department of Health & Human Services, Washington, D.C.
15. Conte D., Fraquelli M., Prati D., Colucci A., Minola E. Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women. Hepatology 2000, 31(3):751-755.
16. Shebl F.M., El-Kamary S.S., Saleh D.A., Abdel-Hamid M., Mikhail N., Allam A., et al. Prospective cohort study of mother-to-infant infection and clearance of hepatitis C in rural Egyptian villages. J Med Virol 2009, 81(6):1024-1031.
17. Kassem A.S., el-Nawawy A.A., Massoud M.N., el-Nazar S.Y., Sobhi E.M. Prevalence of hepatitis C virus (HCV) infection and its vertical transmission in Egyptian pregnant women and their newborns. J Trop Pediatr 2000, 46(4):231-233.
18. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease Centers for disease control and prevention. MMWR Recomm Rep 1998, 47(RR-19):1-39.
19. ACOG Practice Bulletin No 86 Viral hepatitis in pregnancy. Obstet Gynecol 2007, 110(4):941-956.
20. Global policy report on the prevention and control of viral hepatitis in WHO member states 2013, World Health Organization [Internet], [accessed 24.12.14]. Available from:. http://apps.who.int/iris/bitstream/10665/85397/1/9789241564632_eng.pdf.
21. American Academy of Pediatrics Committee on infectious diseases. Pediatrics 1998, 101(3 Pt 1):481-485. Hepatitis C virus infection.
22. Blasig A., Wagner E.C., Pi D., Bigham M., Remple V.P., Craib K.J., et al. Hepatitis C infection among pregnant women in British Columbia: reported prevalence and critical appraisal of current prenatal screening methods. Can J Public Health 2011, 102(2):98-102.
23. Reliability of risk-based screening versus universal screening for hepatitis C virus infection among pregnant women in Egypt Pediatric Academic Societies and Asian Society for Pediatric Research Joint Meeting; May 3-May 6 2014, British Columbia, Canada, Vancouver. M. Hashem, S. El-Kamary, D. Saleh, M. Ehab, S. Sharaf, L. Abdel El-Salam (Eds.).
24. Stoszek S.K., Abdel-Hamid M., Narooz S., El Daly M., Saleh D.A., Mikhail N., et al. Prevalence of and risk factors for hepatitis C in rural pregnant Egyptian women. Trans R Soc Trop Med Hyg 2006, 100(2):102-107.
25. Chao D., Botwin G.J., Morgan T.R. Update on recently approved treatments for hepatitis C. Curr Treat Options Gastroenterol 2014, 12(2):211-228.
26. De Clercq E. Current race in the development of DAAs (direct-acting antivirals) against HCV. Biochem Pharmacol 2014, 89(4):441-452.
27. Schroter M., Zollner B., Schafer P., Laufs R., Feucht H.H. Quantitative detection of hepatitis C virus RNA by light cycler PCR and comparison with two different PCR assays. J Clin Microbiol 2001, 39(2):765-768.
28. Abdelwahab S., Rewisha E., Hashem M., Sobhy M., Galal I., Allam W.R., et al. Risk factors for hepatitis C virus infection among Egyptian healthcare workers in a national liver diseases referral centre. Trans R Soc Trop Med Hyg 2012, 106(2):98-103.
29. Munier A., Marzouk D., Abravanel F., El-Daly M., Taylor S., Mamdouh R., et al. Frequent transient hepatitis C viremia without seroconversion among healthcare workers in Cairo, Egypt. PLoS One 2013, 8(2):e57835.
30. Wasley A., Alter M.J. Epidemiology of hepatitis C: geographic differences and temporal trends. Seminars liver Dis 2000, 20(1):1-16.
31. Frank C., Mohamed M.K., Strickland G.T., Lavanchy D., Arthur R.R., Magder L.S., et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000, 355(9207):887-891.
32. Esmat G., Hashem M., El-Raziky M., El-Akel W., El-Naghy S., El-Koofy N., et al. Risk factors for hepatitis C virus acquisition and predictors of persistence among Egyptian children. Liver Int Official J Int Assoc Study Liver 2012, 32(3):449-456.
33. Medhat A., Shehata M., Magder L.S., Mikhail N., Abdel-Baki L., Nafeh M., et al. Hepatitis c in a community in Upper Egypt: risk factors for infection. Am J Trop Med Hyg 2002, 66(5):633-638.
34. Breban R., Arafa N., Leroy S., Mostafa A., Bakr I., Tondeur L., et al. Effect of preventive and curative interventions on hepatitis C virus transmission in Egypt (ANRS 1211): a modelling study. Lancet Glob Health 2014, 2(9):e541-9.
35. Negro F. Curbing hepatitis C virus spread in Egypt. Lancet Glob health 2014, 2(9):e495-6.
36. Guidelines for the screening, care and treatment of persons with hepatitis C infection 2014, [accessed 24.12.14]. Available from:. http://apps.who.int/iris/bitstream/10665/111747/1/9789241548755_eng.pdf?ua=1%26ua=1.
37. Centers for Disease Control and Prevention Progress toward prevention and control of hepatitis C virus infection-Egypt, 2001-2012. MMWR Morb Mortal Wkly Rep 2012, 61(29):545-549.
38. Egypt starts distributing hepatitis C drug 2014, Ahram Online [Internet], [accessed 24.12.14]. Available from:. http://english.ahram.org.eg/NewsContent/1/64/113238/Egypt/Politics-/Egypt-starts-distributing-Hepatitis-C-drug.aspx.
39. Abdelwahab S.F., Hashem M., Galal I., Sobhy M., Abdel-Ghaffar T.S., Galal G., et al. Incidence of hepatitis C virus infection among Egyptian healthcare workers at high risk of infection. J Clin Virol: Off Publ Pan Am Soc Clin Virol 2013, 57(1):24-28.
40. Terrault N.A., Dodge J.L., Murphy E.L., Tavis J.E., Kiss A., Levin T.R., et al. Sexual transmission of hepatitis C virus among monogamous heterosexual couples: the HCV partners study. Hepatology 2013, 57(3):881-889.